1. Loannides, C. & Whiteside, T. T cell recognition of human tumors: Implication for molecular immunotherapy of cancer.Clin. Immunol. Immunopathol66, 91–106 (1993).

   Article  Google Scholar 

2. Cozzolino, F.et al. Characterization of cells from invaded nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphopro-liferative response.J. Exp. Med.166, 303–318 (1987).

   Article CAS  Google Scholar 

3. Belldegrun, A., Kasid, A., Uppenkamp, M., Topalian, S.L. & Rosenberg, S.A. Human tumor infiltrating lymphocytes: Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.J. Immunol.42, 4520–4526 (1989).

   Google Scholar 

4. Gabrilovich, D., Ciernik, F. & Carbone, D.P. Dendritic cells in anti-tumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.Cell. Immunol.170, 101–110 (1996).

   Article CAS  Google Scholar 

5. Huang, A.Y.C.et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.Science264, 961–965 (1994).

   Article CAS  Google Scholar 

6. Rock, K.L., Rothstein, L., Gamble, S. & Fleishacker, C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.J. Immunol.150, 438–446 (1993).

   CAS PubMed  Google Scholar 

7. Tan, K.C., Hosoi, J., Grabbe, S., Asahina, A. & Granstein, R.D. Epidermal cell presentation of tumor-associated antigens for induction of tolerance.J. Immunol153, 760–767 (1994).

   CAS PubMed  Google Scholar 

8. Watson, G. & Lopez, D.M. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.J. Immunol.155, 3124–3134 (1995).

   CAS PubMed  Google Scholar 

9. Alcalay, J. & Kripke, M.L. Antigen-presenting activity of draining lymph node cells from mice painted with a contact allergen during ultraviolet carcinogenesis.J. Immunol.146, 1717–1721 (1991).

   CAS PubMed  Google Scholar 

10. Erroi, A.et al. IL1 and IL6 released by tumor-associated macrophages from human ovarian carcinoma.Int. J. Cancer41, 65–68 (1989).

    Article  Google Scholar 

11. Steinman, R.M. The dendritic cell system and its role in immunogenicity.Annu. Rev. Immunol.9, 271–296 (1991).

    Article CAS  Google Scholar 

12. Knight, S.C. & Stagg, A.J. Antigen-presenting cell types.Curr. Opin. Immunol.5, 374–382 (1993).

    Article CAS  Google Scholar 

13. Austin, J.M. The dendritic cell system and anti-tumor immunity.In Vivo7, 193–202 (1993).

    Google Scholar 

14. Zitvogel, L.et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.J. Exp. Med.183, 87–97 (1996).

    Article CAS  Google Scholar 

15. Mayordomo, J.I.et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.Nature Med.1, 1297–1302 (1995).

    Article CAS  Google Scholar 

16. Hsu, F.J.et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.Nature Med.2, 52–58 (1996).

    Article CAS  Google Scholar 

17. Tas, M., Simons, P., Balm, F. & Drexhage, H. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormones.Cancer Immunol Immunother.36, 108–114 (1993).

    Article CAS  Google Scholar 

18. Reynolds, N.J.et al. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses.Br. J. Dermatol133, 157–167 (1995).

    Article CAS  Google Scholar 

19. Bergfelt, L., Emilson, A., Lindberg, M. & Scheynius, A. Quantitative and three-dimensional analysis of Langerhans cells in basal cell carcinoma: A comparative study using light microscopy and confocal laser scanning microscopy.Br. J. Dermatol130, 273–280 (1994).

    Article CAS  Google Scholar 

20. Toriyama, K., Wen, D.R., Paul, E. & Cochra, A.J. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin.J. Invest. Dermat.100, 269S–273S (1993).

    Article CAS  Google Scholar 

21. Gabrilovich, D.I., Nadaf, S., Corak, J., Berzofsky, J.A. & Carbone, D.P. Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors.Cell Immunol170, 111–120 (1996).

    Article CAS  Google Scholar 

22. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. GM-CSF and TNF-α cooperate in the generation of dendritic cells.Nature360, 258–261 (1992).

    Article CAS  Google Scholar 

23. Reid, C.D., Stackpoole, A., Meager, A. & Tikerpae, J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34⁺ progenitors in human bone marrow.J. Immunol149, 2681–2688 (1992).

    CAS PubMed  Google Scholar 

24. Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α.J. Exp. Med.179, 1109–1118 (1994).

    Article CAS  Google Scholar 

25. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C.-H. Different signal transduction properties of KDR and FLT1, two receptors for vascular endothelial growth factor.J. Biol Chem.269, 26988–26995 (1994).

    CAS PubMed  Google Scholar 

26. Szabolcs, P.et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.Blood87, 4520–4530 (1996).

    CAS PubMed  Google Scholar 

27. Reid, C.D.L.et al. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood.Blood76, 1139–1149 (1990).

    CAS PubMed  Google Scholar 

28. Roth, P. & Stanley, E.R. The biology of CSF-1 and its receptor.Curr. Topics Microb. Immunol.181, 141–155 (1992).

    CAS  Google Scholar 

29. Rozenzwajg, M., Canque, B. & Gluckman, J.C. Human dendritic cells differentiation pathway from CD34+ hematopoietic precursor cells.Blood87, 535–544 (1996).

    Google Scholar 

30. Leung, D.W., Cachianes, G., Kuang, W.-J., Goeddel, D.V. & Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen.Science246, 1306–1309 (1989).

    Article CAS  Google Scholar 

31. Connolly, D.T.et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.J. Clin. Invest.84, 1470–1478 (1989).

    Article CAS  Google Scholar 

32. Takeshita, S.et al. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit is chemic hind limb model.J. Clin. Invest.93, 662–670 (1994).

    Article CAS  Google Scholar 

33. Ferrara, N., Houck, K., Jakeman, J. & Leung, D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins.Endocrine Rev.13, 18–32 (1992).

    Article CAS  Google Scholar 

34. Kondo, S., Asano, M., Matsuo, K., Ohmori, I. & Suzuki, H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients.Biochem. Biophys. Acta1221, 211–214 (1994).

    Article CAS  Google Scholar 

35. Takano, S.et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.Cancer Res.56, 2185–2190 (1996).

    CAS PubMed  Google Scholar 

36. Shen, H.et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.Blood81, 2767–2773 (1993).

    CAS PubMed  Google Scholar 

37. Hoehn, G.T.et al. Tnk1: A novel intracellular tyrosine kinase gene isolated from human umbilical cord CD34⁺/Lin⁻/CD38⁻ stem/progenitor cells.Oncogene12, 903–913 (1996).

    CAS PubMed  Google Scholar 

38. Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A. & Satow, Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation.Cancer Res.55, 5687–5692 (1995).

    CAS PubMed  Google Scholar 

39. Broxmeyer, H.E.et al. Myeloid progenitor cells regulatory effects of vascular endothelial cell growth factor.Inter. J. Hematol.62, 203–215 (1995).

    Article CAS  Google Scholar 

40. Axelsson, K.et al. Tumor angiogenesis as a prognostic assay for invasive due tal breast carcinoma.J. Natl. Cancer Inst.87, 997–1008 (1995).

    Article CAS  Google Scholar 

41. Bossi, P.et al. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations.Cancer Res.55, 5049–5053 (1995).

    CAS PubMed  Google Scholar 

42. Bochner, B.H.et al. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.J. Natl. Cancer Inst.87, 1603–1612 (1995).

    Article CAS  Google Scholar 

43. Gazdar, A.F. & Oie, H.K. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.Cancer Res.46, 6011–6012 (1986).

    CAS PubMed  Google Scholar 

44. Bhardwaj, N.et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8⁺ T cells.J. Clin. Invest.94, 797–807 (1994).

    Article CAS  Google Scholar 

45. Hayhoe, F.G.J. & Quaglino, D.Haematological Cytochemistry. (Churchill Livingston, London, 1998).

    Google Scholar 

Download references